Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The muscle-type nicotinic acetylcholine receptor (nAChR) is a ligand-gated ion channel found primarily at the neuromuscular junction, where it mediates synaptic transmission between motor neurons and skeletal muscle fibers. Activation of this receptor by acetylcholine leads to rapid depolarization of the postsynaptic membrane, triggering muscle contraction. The receptor is a heteropentamer composed of five subunits arranged symmetrically around a central pore. The adult form is composed of 2 α1, 1 β1, 1 δ, and 1 ε subunit while the fetal form is composed of 2 α1, 1 β1, 1 δ, and 1 γ subunit.
Upon binding acetylcholine, the channel opens transiently to allow cations (Na+, K+) to flow through, resulting in an excitatory postsynaptic potential (EPSP) that can trigger an action potential in muscle fibers leading to contraction. Antagonists block acetylcholine binding or the ion channel itself, preventing depolarization and muscle contraction.
7 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Nicotinic Acetylcholine Receptor (Muscle Type) (nAChR (muscle type)).